For the quarter ended April 2025, DocuSign (DOCU) reported revenue of $763.65 million, up 7.6% over the same period last year. EPS came in at $0.90, compared to $0.82 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $746.98 million, representing a surprise of +2.23%. The company delivered an EPS surprise of +11.11%, with the consensus EPS estimate being $0.81.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how DocuSign performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Non-GAAP billings: $739.61 million versus the five-analyst average estimate of $746.34 million.
- Total Customers: 1.7 million compared to the 1.69 million average estimate based on three analysts.
- Revenue- Professional services and other: $17.45 million compared to the $16.09 million average estimate based on seven analysts. The reported number represents a change of -3.9% year over year.
- Revenue- Subscription: $746.20 million versus $730.77 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +7.9% change.
- Non-GAAP subscription gross profit: $626.87 million compared to the $605.46 million average estimate based on six analysts.
- Non-GAAP professional services and other gross profit: $1.86 million versus $0.19 million estimated by five analysts on average.
View all Key Company Metrics for DocuSign here>>>
Shares of DocuSign have returned +14.1% over the past month versus the Zacks S&P 500 composite's +5.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Docusign Inc. (DOCU): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
